Authors: Elisa S. Roesti, Christina N. Boyle, Daniel T. Zeman, Marcos Sande-Melon, Federico Storni, Gustavo Cabral-Miranda, Alexander Knuth, Thomas A. Lutz, Monique Vogel and Martin F. Bachmann
DOI: https://doi.org/10.3390/vaccines8010116, 2020
Published in: Vaccines
Tags: Immunology, type 2 diabetes mellitus, T2DM, diabetes, insulin, amyloid deposits, islet amyloid polypeptide (IAPP), pancreas, pancreatic islets, virus-like particles, VLPs, hyperglycemia, cytokine, IL-1b